FDA Approved: CHILDRENS XYZAL ALLERGY — Supplemental Application (Chattem, Inc.)

View source ↗

Summary

FDA approved a supplemental application to modify the labeling of CHILDRENS XYZAL ALLERGY (levocetirizine dihydrochloride) for pediatric use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Idiopathic Urticaria

Drugs mentioned

• CHILDRENS XYZAL ALLERGY (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

SUPPL AP for CHILDRENS XYZAL ALLERGY (LEVOCETIRIZINE DIHYDROCHLORIDE)